Saturday, March 2, 2013
Abbot India - a 75 % subsidiary of Illinois based Abbott Laboratories -operating in pharmaceutical, nutritional and diagnostic segments in India.Company is one of the best MNC pharma company currently available at attractive valuation. In past few years ,parent company is very aggressive in India to expand its business.As part of its global integration in 2012 Abbot India merged Solvay India with itself.Abbot group operating in India through three units viz Abbott India, Abbott Healthcare and Abbott True Care.In these days , many MNC pharma companies are keen only to develop their unlisted arms and ignoring the listed units .But Abbot is an exception and the parent is taking equal efforts to grow all of its units .The listed units concentrating in pain management, gastroenterology, thyroid and anesthesiology and Its main brands includes Brufen, Digene , Forane..etc. For FY 2012 Company reported a turnover of Rs.1652 cr ( Rs.1477 Cr in previous year) and a net profit of Rs.145 Cr ( Rs.120 Cr) .EPS was Rs.68 and declared a dividend of Rs.17. A good stock for investment @ CMP Rs.1360 for long term investors. .
Link to Company website HERE